4.7 Article

A human post-mortem brain model for the standardization of multi-centre MRI studies

Journal

NEUROIMAGE
Volume 110, Issue -, Pages 11-21

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.neuroimage.2015.01.028

Keywords

Multi-centre MRI studies; Standardization; Post-mortem brain; Quantitative MRI

Funding

  1. German Competence Network Multiple Sclerosis - German Federal Ministry of Education and Research
  2. BMBF (Brain Imaging Center Frankfurt) [DLR 01GO0203]
  3. German Research Foundation [CRC-TR-128, ZA 233/1-1]

Ask authors/readers for more resources

Multi-centre MRI studies of the brain are essential for enrolling large and diverse patient cohorts, as required for the investigation of heterogeneous neurological and psychiatric diseases. However, the multi-site comparison of standard MRI data sets that are weighted with respect to tissue parameters such as the relaxation times (T1, T2) and proton density (PD) may be problematic, as signal intensities and image contrasts depend on site-specific details such as the sequences used, imaging parameters, and sensitivity profiles of the radiofrequency (RF) coils. Water or gel phantoms are frequently used for long-term and/or inter-site quality assessment. However, these phantoms hardly mimic the structure, shape, size or tissue distribution of the human brain. The goals of this study were: (1) to validate the long-term stability of a human post-mortem brain phantom, performing quantitative mapping of T1, T2, and PD, and the magnetization transfer ratio (MTR) over a period of 18 months; (2) to acquire and analyse data for this phantom and the brain of a healthy control (HC) in a multi-centre study for MRI protocol standardization in four centres, while conducting a voxel-wise as well as whole brain grey (GM) and white matter (WM) tissue volume comparison. MTR, T2, and the quotient of PD in WM and GM were stable in the post-mortem brain with no significant changes. T1 was found to decrease from 267/236 ms (GM/WM) to 234/216 ms between 5 and 17 weeks post embedment, stabilizing during an 18-month period following the first scan at about 215/190 ms. The volumetric measures, based on T1-weighted MP-RAGE images obtained at all participating centres, revealed inter-and intra-centre variations in the evaluated GM and WM volumes that displayed similar trends in both the post-mortem brain as well as the HC. At a confidence level of 95%, brain regions such as the brainstem, deep GM structures as well as boundaries between GM and WM tissues were found to be less reproducible than other brain regions in all participating centres. The results demonstrate that a post-mortem brain phantom may be used as a reliable tool for multi-centre MR studies. (C) 2015 Published by Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Biochemistry & Molecular Biology

Chemical, pharmacodynamic and pharmacokinetic characterization of the GluN2B receptor antagonist 3-(4-phenylbutyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-1,7-diol - starting point for PET tracer development

Marvin Korff, Ruben Steigerwald, Elena Bechthold, Dirk Schepmann, Julian A. Schreiber, Sven G. Meuth, Guiscard Seebohm, Bernhard Wuensch

Summary: GluN2B-NMDA receptors play a key role in neurological and neurodegenerative disorders. A new GluN2B-NMDA receptor modulator was developed with promising affinity and pharmacological activity, which could be suitable for human application.

BIOLOGICAL CHEMISTRY (2023)

Article Endocrinology & Metabolism

Hyperbaric oxygen rapidly improves tissue-specific insulin sensitivity and mitochondrial capacity in humans with type 2 diabetes: a randomised placebo-controlled crossover trial

Theresia Sarabhai, Lucia Mastrototaro, Sabine Kahl, Gidon J. Boenhof, Marc Jonuscheit, Pavel Bobrov, Hisayuki Katsuyama, Rainer Guthoff, Martin Wolkersdorfer, Christian Herder, Sven G. Meuth, Sven Dreyer, Michael Roden

Summary: This study aimed to examine the effects of hyperbaric oxygen therapy on whole-body glucose metabolism in individuals with type 2 diabetes. The results showed that hyperbaric oxygen therapy decreased fasting blood glucose, improved whole-body insulin sensitivity, and achieved this improvement through decreasing endoplasmic reticulum stress and increasing mitochondrial function.

DIABETOLOGIA (2023)

Article Cardiac & Cardiovascular Systems

Total atrial conduction time provides novel information in prediction for stroke in patients with sinus rhythm

A. G. Bejinariu, M. Schilling, P. Mueller, L. Clasen, S. Gerguri, S. Angendohr, S. Katsianos, J. Schmidt, C. Brinkmeyer, S. G. Meuth, M. Kelm, H. Makimoto

Summary: The total atrial conduction time (TACT) measured by echocardiography can predict the risk of atrial fibrillation (AF) and stroke; adding TACT to the revised Framingham stroke risk profile (rFSRP) significantly improves the prediction of stroke incidence.

HEART AND VESSELS (2023)

Article Clinical Neurology

Resting-state functional MRI in multicenter studies on multiple sclerosis: a report on raw data quality and functional connectivity features from the Italian Neuroimaging Network Initiative

Alessandro Pasquale De Rosa, Fabrizio Esposito, Paola Valsasina, Alessandro D'Ambrosio, Alvino Bisecco, Maria A. Rocca, Silvia Tommasin, Chiara Marzi, Nicola De Stefano, Marco Battaglini, Patrizia Pantano, Mario Cirillo, Gioacchino Tedeschi, Massimo Filippi, Antonio Gallo

Summary: The Italian Neuroimaging Network Initiative (INNI) is an expanding database of brain MRI data from multiple sclerosis (MS) patients, with a focus on the quality of the data and functional connectivity (FC) features after preprocessing. The study found that FC features showed inter-site and site-specific inter-group effects, and significant reductions were observed in somatomotor and limbic networks in MS patients. The implemented procedures provide technical information and reference for future RS-fMRI studies within INNI.

JOURNAL OF NEUROLOGY (2023)

Editorial Material Clinical Neurology

Cerebellar cryptococcomas

Carlo Manco, Nicola De Stefano, Roberto Marconi

NEUROLOGICAL SCIENCES (2023)

Article Medicine, General & Internal

Predictors for insufficient SARS-CoV-2 vaccination response upon treatment in multiple sclerosis

Muriel Schraad, Timo Uphaus, Stefan Runkel, Walter Hitzler, Stefan Bittner, Frauke Zipp

Summary: This study aimed to investigate the response of multiple sclerosis (MS) patients to SARS-CoV-2 vaccination after disease-modifying therapy (DMT). The findings suggest that anti-CD20 treatment, decreased CD8 levels, and non-selective S1P treatment may lead to an insufficient response to SARS-CoV-2 vaccination. Close monitoring of anti-spike antibodies is recommended to customize vaccination regimens for these patients.

EBIOMEDICINE (2023)

Article Neurosciences

Differential effects of mutations of POPDC proteins on heteromeric interaction and membrane trafficking

Alexander H. Swan, Roland F. R. Schindler, Marco Savarese, Isabelle Mayer, Susanne Rinne, Felix Bleser, Anne Schaenzer, Andreas Hahn, Mario Sabatelli, Francesco Perna, Kathryn Chapman, Mark Pfuhl, Alan C. Spivey, Niels Decher, Bjarne Udd, Giorgio Tasca, Thomas Brand

Summary: The POPDC genes encode sarcolemma-localized cAMP effector proteins and mutations in BVES are associated with muscular dystrophy and cardiac arrhythmia. Muscle biopsies showed impaired membrane trafficking of POPDC isoforms in patients. The study investigated the interaction of POPDC proteins and found that they interact through a helix-helix interface at the C-terminus. Mutations in POPDC proteins that affect membrane localization disrupt complex formation, while mutations that maintain protein-protein interaction likely affect other essential functions.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2023)

Article Clinical Neurology

Specific Patterns of Immune Cell Dynamics May Explain the Early Onset and Prolonged Efficacy of Cladribine Tablets A MAGNIFY-MS Substudy

Heinz Wiendl, Klaus Schmierer, Suzanne Hodgkinson, Tobias Derfuss, Andrew Chan, Finn Sellebjerg, Anat Achiron, Xavier Montalban, Alexandre Prat, Nicola De Stefano, Frederik Barkhof, Letizia Leocani, Patrick Vermersch, Anita Chudecka, Claire Mwape, Kristina H. Holmberg, Ursula Boschert, Sanjeev Roy, MAGNIFY-MS Study Grp

Summary: Cladribine tablets cause a reduction in lymphocytes, with a predominant effect on B-cell and T-cell counts. The MAGNIFY-MS substudy reports the dynamic changes on multiple peripheral blood mononuclear cell (PBMC) subtypes and immunoglobulin (Ig) levels over 12 months after the first course of cladribine tablets in patients with highly active relapsing multiple sclerosis (MS).

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2023)

Article Clinical Neurology

Serum Neurofilament Identifies Patients With Multiple Sclerosis With Severe Focal Axonal Damage in a 6-Year Longitudinal Cohort

Falk Steffen, Timo Uphaus, Nina Ripfel, Vinzenz Fleischer, Muriel Schraad, Gabriel Gonzalez-Escamilla, Sinah Engel, Sergiu Groppa, Frauke Zipp, Stefan Bittner

Summary: Measuring serum neurofilament light chain (sNfL) levels can predict disease severity and future evidence of disease activity in patients with multiple sclerosis (MS). sNfL levels are also associated with the development of neurodegenerative damage.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2023)

Article Clinical Neurology

Prognostic value of single-subject grey matter networks in early multiple sclerosis

Vinzenz Fleischer, Gabriel Gonzalez-Escamilla, Deborah Pareto, Alex Rovira, Jaume Sastre-Garriga, Piotr Sowa, Einar A. Hogestol, Hanne F. Harbo, Barbara Bellenberg, Carsten Lukas, Serena Ruggieri, Claudio Gasperini, Tomas Uher, Manuela Vaneckova, Stefan Bittner, Ahmed E. Othman, Sara Collorone, Ahmed T. Toosy, Sven G. Meuth, Frauke Zipp, Frederik Barkhof, Olga Ciccarelli, Sergiu Groppa

Summary: This study investigated the prognostic value of longitudinal structural networks in predicting 5-year Expanded Disability Status Scale (EDSS) progression in relapsing-remitting multiple sclerosis (RRMS) patients. The study found that changes in network degree and global efficiency can predict disability accumulation independent of disease activity, and these network measures outperform conventional MRI predictors in predicting EDSS worsening.

BRAIN (2023)

Editorial Material Immunology

IL-17 receptor goes solo in autoimmune inflammation

Stefan Bittner, Frauke Zipp

Summary: IL-17-blocking antibodies have limited clinical effect in certain autoimmune diseases. This study demonstrates that SHP2-Act1 complexes can mediate IL-17R signaling autonomously, even in the absence of the IL-17 ligand itself.

IMMUNITY (2023)

Review Clinical Neurology

Implications of immunometabolism for smouldering MS pathology and therapy

Stefan Bittner, Katrin Pape, Luisa Klotz, Frauke Zipp

Summary: Worsening clinical symptoms in patients with multiple sclerosis (MS) are caused by inflammation specifically occurring within the CNS. This chronic and non-relapsing immune-mediated mechanism of disease progression, called "smouldering inflammation," is sustained by local factors in the CNS and explains why current MS treatments do not adequately target it. This review summarizes the current understanding of the local inflammatory microenvironment in smouldering inflammation, its interaction with immune cell metabolism, and potential treatments for preventing neurodegenerative damage.

NATURE REVIEWS NEUROLOGY (2023)

Article Clinical Neurology

Quantification of Thalamic Atrophy in MS: From the Multicenter Italian Neuroimaging Network Initiative Data Set to Clinical Application

Loredana Storelli, Elisabetta Pagani, Patrizia Pantano, Antonio Gallo, Nicola De Stefano, Maria A. Rocca, Massimo Filippi

Summary: The use of FSL-MIST multimodal segmentation method improves the robustness of results and enables better detection of small variations in thalamic volumes.

AMERICAN JOURNAL OF NEURORADIOLOGY (2023)

Article Clinical Neurology

Disease progression in the first 5 years of treatment in multiple sclerosis: Predictive value of early brain and lesion volume changes

Rozemarijn M. Mattiesing, Eline Kramer, Eva M. M. Strijbis, Iman Brouwer, Ronald A. van Schijndel, Giordano Gentile, Marco Battaglini, Nicola De Stefano, Bernard M. J. Uitdehaag, Frederik Barkhof, Hugo Vrenken, Menno M. Schoonheim

Summary: The degree of inflammation and neurodegeneration after treatment initiation in multiple sclerosis (MS) can predict disease progression. This study found that global atrophy and/or pseudo-atrophy as well as positive lesion activity in MRI results during the first and second years of treatment were related to an increased probability and faster conversion to clinically definite MS. Negative lesion activity in the first year and slower central atrophy in the second year were predictive of disability progression.

MULTIPLE SCLEROSIS JOURNAL (2023)

Letter Neurosciences

24S-Hydroxycholesterol and Cerebellar Degeneration: Insights from SCA2

Sara Locci, Valentina Nidiaci, Nicola De Stefano, Valerio Leoni, Andrea Mignarri

CEREBELLUM (2023)

Article Neurosciences

Solving large-scale MEG/EEG source localisation and functional connectivity problems simultaneously using state-space models

Jose Sanchez-Bornot, Roberto C. Sotero, J. A. Scott Kelso, Ozguer Simsek, Damien Coyle

Summary: This study proposes a multi-penalized state-space model for analyzing unobserved dynamics, using a data-driven regularization method. Novel algorithms are developed to solve the model, and a cross-validation method is introduced to evaluate regularization parameters. The effectiveness of this method is validated through simulations and real data analysis, enabling a more accurate exploration of cognitive brain functions.

NEUROIMAGE (2024)